Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1683
    +0.0027 (+0.23%)
     
  • GBP/USD

    1.2493
    -0.0018 (-0.14%)
     
  • Bitcoin GBP

    51,188.16
    -722.11 (-1.39%)
     
  • CMC Crypto 200

    1,331.09
    -65.44 (-4.68%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.65
    +0.08 (+0.10%)
     
  • GOLD FUTURES

    2,348.70
    +6.20 (+0.26%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Medtronic Earnings, Revenue Beat in Q1

Medtronic Earnings, Revenue Beat in Q1
Medtronic Earnings, Revenue Beat in Q1

Investing.com - Medtronic reported first quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.

The firm reported earnings per share of $1.26 on revenue of $7.49B. Analysts polled by Investing.com anticipated EPS of $1.18 on revenue of $7.4B. That compared to EPS of $1.17 on revenue of $7.38B in the same period a year earlier. The company had reported EPS of $1.54 on revenue of $8.15B in the previous quarter.

Medtronic follows other major Healthcare sector earnings this month

On July 30, Merck&Co reported second quarter EPS of $1.3 on revenue of $11.76B, compared to forecasts of EPS of $1.16 on revenue of $10.96B.

ADVERTISEMENT

Pfizer earnings beat analysts' expectations on July 29, with second quarter EPS of $0.8 on revenue of $13.26B. Investing.com analysts expected EPS of $0.75 on revenue of $13.4B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Tod's founder Della Valle further raises stake to 81.2%

U.S. yield curve: Invert, steepen, repeat

Home Depot Cuts Sales Outlook on Tariffs, Lumber Price Deflation